Smith & Nephew PLC SN.-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 02/03/23 GMT
1,188.00quote price arrow up+38.50 (+3.35%)
52 week range
959.20 - 1,344.00
Loading...
  • Open1,144.50
  • Day High1,189.50
  • Day Low1,144.50
  • Prev Close1,149.50
  • 52 Week High1,344.00
  • 52 Week High Date02/28/22
  • 52 Week Low959.20
  • 52 Week Low Date10/13/22

Key Stats

  • Market Cap12,100.27M
  • Shares Out872.47M
  • 10 Day Average Volume2.26M
  • Dividend31.31
  • Dividend Yield2.64%
  • Beta0.8
  • YTD % Change7.08

KEY STATS

  • Open1,144.50
  • Day High1,189.50
  • Day Low1,144.50
  • Prev Close1,149.50
  • 52 Week High1,344.00
  • 52 Week High Date02/28/22
  • 52 Week Low959.20
  • 52 Week Low Date10/13/22
  • Market Cap12,100.27M
  • Shares Out872.47M
  • 10 Day Average Volume2.26M
  • Dividend31.31
  • Dividend Yield2.64%
  • Beta0.8
  • YTD % Change7.08

RATIOS/PROFITABILITY

  • EPS (TTM)46.75
  • P/E (TTM)25.41
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/29/2022
  • Div Amount12.91
  • Split Date-
  • Split Factor-

Latest On Smith & Nephew PLC

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. The Company operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints...
Roberto Quarta
Non-Executive Independent Chairman of the Board
Deepak Nath Ph.D.
Chief Executive Officer
Anne-Francoise Nesmes
Chief Financial Officer, Executive Director
Address
Building 5, Croxley Park, Hatters Lane
Watford
WD18 8YE
United Kingdom